Search alternatives:
significantly improve » significantly improved (Expand Search)
significantly lower » significantly higher (Expand Search)
improve decrease » improve disease (Expand Search), improved urease (Expand Search), improves disease (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
significantly improve » significantly improved (Expand Search)
significantly lower » significantly higher (Expand Search)
improve decrease » improve disease (Expand Search), improved urease (Expand Search), improves disease (Expand Search)
lower decrease » larger decrease (Expand Search), linear decrease (Expand Search), teer decrease (Expand Search)
-
1701
-
1702
-
1703
Line graph showing the values of inflammatory cytokines at baseline and after treatment.
Published 2025Subjects: -
1704
Baseline descriptive characteristics of trial participants (n = 140) with and without dizziness.
Published 2024Subjects: -
1705
-
1706
-
1707
-
1708
Frequency distribution of SOLEC at baseline and follow-ups in the NSEIT and NSE groups.
Published 2024Subjects: -
1709
-
1710
Baseline and Post-Treatment Results of Echocardiographic Variables in Each Experimental Group.
Published 2025Subjects: -
1711
-
1712
-
1713
Baseline descriptive characteristics of trial participants with dizziness, by treatment group.
Published 2024Subjects: -
1714
-
1715
Baseline and Post-Treatment Serum Cytokine Levels in Each Investigational Group.
Published 2025Subjects: -
1716
-
1717
Baseline and Post-Treatment Serum Levels of NT-proBNP in Each Investigational Group.
Published 2025Subjects: -
1718
Variables obtained from the SF-36 quality of life questionnaire in each experimental group.
Published 2025Subjects: -
1719
-
1720